Hannah Maude

I am currently a postdoctoral Research Associate in the Regulatory Genomics and Metabolic Disease group, researching the functional genomics landscape of the liver under conditions of hyperlipidemia and hyperglycemia. I specialise in bioinformatics, including the analysis of whole-genome, whole-exome and targeted sequence data, as well as RNA-seq, ATAC-seq and ChIP-seq data (see the Cebola Lab RNA-seq and ATAC-seq online tutorials). I completed my PhD in 2019, titled 'the role of mitochondrial dysfunction in the onset of Type 2 Diabetes', carried out with Dr Toby Andrew at Imperial College. My interests cover complex and rare diseases, including the heritability of metabolic pathways and insulin resistance, mitochondrial diseases and non-alcoholic fatty liver disease. In particular, I study the roles of rare variants and non-coding, functional mutations in causing disease, including undiagnosed cases of mitochondrial disease registered in the 100,000 Genomics Project. Professional affiliations: Genetics Society Local Ambassador Imperial College (White City) and Society for Endocrinology Media Ambassador (see examples quotes in The Guardian and The Times). Science Communication: I host the DNA& podcast funded by the UK Genetics Society and regularly participate in science engagement, including at the Great Exhibition Road festival and Imperial Lates. Expert quotes provided as a SfE Media Ambassador can be seen in the Guardian, Times, Telegraph, Insider and Evening Standard. In my spare time, I love to read popular science novels (and dream of writing my own!), paint, and play video games. For thoughts, discussions and general conversation, drop a message via my twitter!

• Faculty of Medicine